Fibromyalgia
BEMER for Fibromyalgia
Addressing pain, fatigue, and sleep at the vascular level.
About this condition
Fibromyalgia is a chronic pain condition characterised by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive symptoms — commonly described as "fibro fog." It affects approximately 2–4% of the population. The condition remains challenging because fibromyalgia is a disorder of pain processing and neurovascular function — not a structural or inflammatory condition in the conventional sense. The pain amplification characteristic of fibromyalgia involves central sensitisation, autonomic nervous system dysregulation, and critically — impaired microcirculatory function in muscle tissue. This is where BEMER Physical Vascular Therapy is most directly relevant: targeting the peripheral vascular dimension of fibromyalgia that sits beneath the pain, fatigue, and sleep disruption.
How BEMER helps
Research has consistently demonstrated impaired microcirculation in people with fibromyalgia. Muscle tissue that receives inadequate oxygen and accumulates metabolic waste becomes pain-sensitised, amplifying the central sensitisation already present — a cycle genuinely driven by vascular dysfunction. BEMER interrupts this cycle by restoring vasomotion and improving microcirculatory flow in muscle tissue. Better oxygen delivery, accelerated waste clearance, and reduced peripheral hypoxic stress together reduce the pain amplification loop. BEMER also shifts autonomic tone toward parasympathetic balance — directly addressing the sympathetic dominance characteristic of fibromyalgia — and improves sleep architecture, which itself modulates pain sensitisation. Fatigue is addressed through both improved cellular oxygenation and better sleep quality.
Key benefits
Please note: Research on PEMF therapy in fibromyalgia has demonstrated improvements in pain severity, fatigue, sleep quality, and functional capacity. Studies on microvascular function in fibromyalgia provide the mechanistic rationale for BEMER's specific targeting of vasomotion. European rheumatologists and pain specialists have incorporated BEMER into fibromyalgia management protocols. BEMER's Class IIa medical device classification ensures quality and safety standards appropriate for use in this population.